CCMI
BSX icon

Creative Capital Management Investments’s Boston Scientific BSX Stock Holding History

Creative Capital Management Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
267
+47
+21% +$2.55K ﹤0.01% 273
2026
Q1 		$13.8K Hold
220
– – ﹤0.01% 194
2025
Q4 		$21K Hold
220
– – 0.01% 172
2025
Q3 		$21.5K Hold
220
– – 0.01% 169
2025
Q2 		$23.6K Hold
220
– – 0.01% 162
2025
Q1 		$22.2K Hold
220
– – 0.01% 147
2024
Q4 		$19.6K Hold
220
– – 0.01% 156
2024
Q3 		$18.4K Hold
220
– – 0.01% 143
2024
Q2 		$16.9K Hold
220
– – 0.01% 135
2024
Q1 		$15.1K Hold
220
– – 0.01% 138
2023
Q4 		$12.7K Hold
220
– – 0.01% 141
2023
Q3 		$11.6K Hold
220
– – 0.01% 146
2023
Q2 		$11.9K Hold
220
– – 0.01% 141
2023
Q1 		$11K Buy
+220
New +$10.4K 0.01% 154

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Creative Capital Management Investments's BSX Position: Q2 2026 in Review

Creative Capital Management Investments increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $2.55K and bringing the position to 267 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

Creative Capital Management Investments first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $23.6K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Creative Capital Management Investments held 267 shares of Boston Scientific worth $11.4K as of Q2 2026.
  • Creative Capital Management Investments bought 47 Boston Scientific shares in Q2 2026, an estimated $2.55K.
  • Boston Scientific made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #273 holding.
  • Creative Capital Management Investments first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Creative Capital Management Investments's Boston Scientific position peaked at $23.6K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.